Page last updated: 2024-11-11

4'-methyl-alpha-pyrrolidinopropiophenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

4'-methyl-alpha-pyrrolidinopropiophenone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6430745
CHEBI ID181456
SCHEMBL ID17644179
MeSH IDM0433821

Synonyms (24)

Synonym
1-(4-methylphenyl)-2-pyrrolidin-1-ylpropan-1-one
CHEBI:181456
4'-methyl-alpha-pyrrolidinopropiophenone
28117-80-8
4'-methyl-.alpha.-pyrrolidinopropiophenone
4-meppp
unii-0ty023967i
0ty023967i ,
dea no. 7498
AKOS009049776
4'-methyl-a-pyrrolidinopropiophenone
APSJUNFBAXIXLK-UHFFFAOYSA-N
4'-methyl-.alpha.-pyrrolidino-propiophenone
1-propanone, 1-(4-methylphenyl)-2-(1-pyrrolidinyl)-
propiophenone, 4'-methyl-2-(1-pyrrolidinyl)-
m.alpha.ppp
1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-propanone
meppp
J1.756.931G ,
SCHEMBL17644179
4'-meppp
DTXSID80891438
Q4043329
PD046498
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aromatic ketoneA ketone in which the carbonyl group is attached to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]